Recommended

Jury rules against dad trying to save his 7-year-old son from gender transition

LGBT activists and their supporters rally in support of transgender people on the steps of New York City Hall, October 24, 2018 in New York City.
LGBT activists and their supporters rally in support of transgender people on the steps of New York City Hall, October 24, 2018 in New York City. | Drew Angerer/Getty Images

A Dallas jury has decided against a dad fighting to save his 7-year-old son from a gender transition his ex-wife is facilitating.

Eleven of 12 jurors decided not to grant Jeffrey Younger sole conservatorship over his twin sons, LifeSite News reported Monday. Thus, Dr. Anne Georgulas, a pediatrician in Coppell, Texas, who's the legal mother of the twins, is now able to continue "transitioning" one of the boys, named James, into "Luna," a name she chose. 

The jury’s decision could mean that Younger, despite his objections, will be forced to “affirm” his son as female, and be required to take a class on transgenderism, LifeSite News reported.

Get Our Latest News for FREE

Subscribe to get daily/weekly email with the top stories (plus special offers!) from The Christian Post. Be the first to know.

Georgulas became pregnant with the twin boys, Jude and James, by using fertilized eggs from a third-party donor. 

The court petition was brought about by Georgulas, who asked the court that Younger be forbidden from calling the boy "James," and that he prohibited from bringing him around people who do not affirm that he is the opposite sex.

Her witnesses during the proceedings were mostly therapists or counselors who asserted that James told them he was a girl who wished to be referred to by a female name, The Texan reported.

Younger's witnesses were medical experts who described how "social transition" often leads to a medical transition.

Drugs used to halt puberty in children are often administered at Tanner stage II, about the time when the pubertal signals in the brain begin, endocrinologists have noted. One of the hormone blockers, Lupron, is routinely used to treat prostate cancer. The drug has never been approved by the FDA for use in children with gender dysphoria. Puberty blockers are the precursor to cross-sex hormones, which nearly all gender dysphoric youth go on to take.

"Younger could appeal the jury’s decision, but it would be an expensive and time-consuming endeavor that might take a year. By that time, Younger is concerned that James could begin puberty — and begin being treated with puberty blockers," The Texan reported.

James' father has written on his website SaveJames.com: "When James is with me, he shows no signs of wanting to be a girl when given the choice. Even when in female company, away from me, James rejects a female gender expression."

The judge will read her ruling regarding child support and conservatorship on Wednesday.

The development is the latest in a string of custody battles and court cases in the United States and Canada centering around parental rights and their transgender-identifying children.

Earlier this year, the British Columbia Supreme Court ruled that a 14-year-old girl was to be allowed to begin taking gender-transition drugs to appear more like a male and issued a "protection order" in an attempt to stop her father from continuing to privately or publicly refer to his daughter as female.

The father's reference to his daughter as female, including his use of female pronouns, was deemed "family violence."

In February 2018, Judge Sylvia Hendon in Hamilton County, Ohio, ruled that a 17-year-old was to be removed from the custody of her parents over their objections to transgender medicine. The teen was transferred into the care of her grandparents.

Was this article helpful?

Help keep The Christian Post free for everyone.

By making a recurring donation or a one-time donation of any amount, you're helping to keep CP's articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.